Company page
Enimmune Corporation
Enimmune Corporation, trading under the ticker 6564, is a public company based in Taiwan. With a market capitalization of approximately 37.4 million USD, the company operates within the biotechnology sector. Enimmune focuses on developing innovative solutions in the field of immunology.
- Ticker
- 6564:TPEX
- Asset type
- Stock
- Market cap
- $37.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TPEX
- Currency
- TWD